
Zijing Zhang
Articles
-
Jan 22, 2025 |
mdpi.com | Zijing Zhang |Yuchen Li |Qi Xun Xia |Qing Yu
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Nov 27, 2023 |
mdpi.com | Zijing Zhang |Fan Jia |Yuan Zhao
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Oct 10, 2023 |
futuremedicine.com | Zijing Zhang |Hongying Wang |Yiting Jin |Jian Zhou
Breast cancer is the most common malignancy and causes the second-highest number of cancer deaths among women worldwide [1,2]. Surgical resection is recommended for patients with breast cancer at the early stage, which might contribute to satisfactory survival outcomes [3–5]. However, once patients develop invasive breast cancer, their treatment is limited and survival is poor; thus, early screening is imperative [6,7].
-
Jul 4, 2023 |
nature.com | Zijing Zhang |Jingyi Zhou
AbstractBackgroundThe effectiveness of conservative treatment of endometrial carcinoma (EC) with oral progesterone therapy, such as medroxyprogesterone acetate (MPA), can be blunted due to primary or acquired resistance, but the underlying mechanisms remain incompletely defined. MethodsGenome-wide CRISPR screening was performed to identify potential regulators in response to MPA in Ishikawa cells.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →